Euronext Paris · Healthcare
Invest in Plant Advanced Technologies stock from India
Indian and foreign residents can buy Plant Advanced Technologies (ALPAT) shares directly through Paasa.
By Paasa · Updated
Plant Advanced Technologies at a glance
- Price
- €4.20-€0.04 (0.94%)
- Market cap
- €4.78M
- Day range
- €4.20 – €4.20
- P/E
- 8.24
- Dividend yield
- None
- Volume
- 160.00
- 1 month
- -2.78%
- 6 months
- -46.84%
- YTD
- -48.78%
- 1 year
- -52.81%
- 5 years
- -79.51%
Plant Advanced Technologies statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €1.1M | €1.9M | €1.7M | €2.3M | €2.3M |
| Gross profit | −€693.7K | €2.2M | €2.2M | −€4.7M | −€2.7M |
| Operating income | −€693.7K | €215.0K | −€778.2K | −€1.9M | −€3.0M |
| Net income | €569.4K | €935.1K | €79.2K | −€849.0K | −€1.1M |
| Earnings per share | €0.51 | €0.84 | €0.07 | −€0.78 | −€1.04 |
| EBITDA | −€693.7K | €956.5K | €185.8K | −€744.0K | −€1.3M |
| Total assets | €16.4M | €16.0M | €14.9M | €17.1M | €17.1M |
| Total debt | €3.6M | €3.4M | €4.4M | €6.0M | €6.1M |
| Cash and short-term investments | €55.0K | €79.7K | €0.0 | €669.0K | €2.5M |
| Shareholders' equity | €9.8M | €9.2M | €8.1M | €5.5M | €6.4M |
| Operating cash flow | €0.0 | €2.5M | €1.8M | −€274.0 | −€388.0 |
| Free cash flow | €0.0 | €2.1M | €972.5K | −€479.0 | −€504.0 |
| Capital expenditure | €0.0 | −€412.4K | −€875.6K | −€205.0 | −€116.0 |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Mauna Kea Technologies | ALMKT.PA | €0.11 | €22.06M |
| Valbiotis | ALVAL.PA | €0.59 | €21.08M |
| Biosynex | ALBIO.PA | €0.84 | €15.48M |
| Euromedis Groupe | ALEMG.PA | €5.05 | €14.42M |
| TME Pharma | ALTME.PA | €0.12 | €11.28M |
| NFL Biosciences | ALNFL.PA | €0.62 | €7.86M |
| AMA | ALAMA.PA | €0.11 | €6.13M |
| Media Lab | MLLAB.PA | €2.40 | €5.69M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Plant Advanced Technologies from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search ALPAT and buy
Find Plant Advanced Technologies by name or by its ticker, ALPAT, and place your order.
Why invest in Plant Advanced Technologies from India
What Plant Advanced Technologies does
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies operates in the Biotechnology industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Plant Advanced Technologies stock from India?
Yes. Indian residents and NRIs can buy Plant Advanced Technologies (ALPAT) shares directly through Paasa. Plant Advanced Technologies is listed on Euronext Paris, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Plant Advanced Technologies shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.